Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

MetricLHLabcorpDGXQuest DiagnosticsDVADaVita
Snapshot
Price$254.43$193.58$209.68
Market cap$20.98B$21.59B$13.35B
Valuation
P/E22.3x21x17.1x
Forward P/E17.2x18.3x16x
Growth
Revenue growth7.3%11.0%6.7%
EPS growth30.2%14.9%6.6%
Profitability
Net margin6.7%9.1%5.7%
ROE10.9%14.1%181.2%
Balance sheet & cash
Debt / equity0.66x0.82x77.99x
Free cash flow yield5.2%5.4%8.2%
Dividend yield1.1%1.7%—
Verdict
Investment ratingFavorable· 58Neutral· 57Neutral· 53

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearLHtoday $254DGXtoday $194DVAtoday $210
2027$248.37 – $364.28+43% CAGR$166.79 – $244.62+26% CAGR$167.65 – $245.89+17% CAGR
2028$323.28 – $474.15+37% CAGR$191.61 – $281.02+20% CAGR$178.74 – $262.15+12% CAGR
2029$420.79 – $617.15+34% CAGR$220.12 – $322.84+19% CAGR$190.55 – $279.48+10% CAGR
2030$547.70 – $803.29+33% CAGR$252.87 – $370.88+18% CAGR$203.15 – $297.95+9% CAGR
2031$712.88 – $1,045.56+33% CAGR$290.50 – $426.06+17% CAGR$216.57 – $317.64+9% CAGR
5-yr CAGR22.9% – 32.7%8.5% – 17.1%0.6% – 8.7%